Material Type

• Blood (whole) (3)
• Buffy coat (1)
• Dried whole blood (3)
• Isolated peripheral blood mononuclear cells (non viable) (2)
• Other (2)
• Plasma (double spun) (1)
• Plasma (single spun) (3)
• Red Blood Cells (1)
• Saliva (2)
• Serum (7)
• Stool (1)
• Swab medium (2)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Affected (1)
• Not applicable (6)

Storage Temperature

• -85°C to -60°C (7)

Preservation Type

• N/A (2)

Associated Data

• Biomarker datasets (1)
• Clinical records (6)
• Followup records (6)
• Freezer temperature logs (3)
• Genomic datasets (1)
• Imaging data (1)
• Microbiological results (3)
• Participant Ethnicity (2)
• Physiological/biochemical measurements (3)
• Pre-analytical data (2)
• Quality indicators (2)
• Survey data (6)
• Treatment records (4)

Timeframe

• Immediate (1)
• 0 - 3 months (7)
• 3 - 6 months (2)
• > 6 months (1)

Participant Count

• 101 - 500 (7)

Sex

• Both sexes (7)

Age Range

• Young child (2 - 6 years) (1)
• Child (6 - 12 years) (3)
• Adolescent (12 - 18 years) (3)
• Young adult (18 - 40 years) (4)
• Adult (> 40 years) (2)

Biobank Services

• Ability to recontact (4)
• Cell culture (3)
• Data analytics (2)
• Digital imaging (1)
• Infectious strain isolation (1)
• Molecular Extractions (2)
• Nucleic acid extraction (3)

Collection Type

• Case-control (1)
• Cross-sectional (2)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (6)
• No Disease area restriction (7)
• No Export restriction (7)
• No Genetic analysis restriction (6)
• No Human genetic analysis restriction (5)
• No restrictions (2)
• No Project specific restriction (7)
• No Scope of use restriction (5)

Collection Status

• Completed (2)
• In progress (6)

Access Condition

• Open to applicants (4)
• Open only through collaboration (3)

Country

• Belgium (1)
• Peru (3)
• Philippines (1)
• South Africa (1)
• Spain (1)
• United States (1)

County